Moxifloxacin 400 Mg/250 Ml Fresenius Solution For Infusion 400 mg/250 ml Solution for infusion
PDF Leaflet Revision Date: 27 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Severe and/or complicated infections caused by moxifloxacin-sensitive bacteria.
Dosage (summary)
400 mg once daily; may switch to oral as soon as feasible.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Warfarin
- Antidiabetics
- ACE inhibitors
Contraindications
- Hypersensitivity to moxifloxacin
- History of tendon disorders
- Myasthenia gravis
- Children under 18
Common side effects
- Nausea
- Diarrhoea
- Headache
- Dizziness
Counselling Points
- Avoid exposure to sunlight
- Monitor for signs of tendon pain
- Report any psychiatric symptoms
Serious warnings
- QT prolongation
- Risk of tendon rupture
- Severe allergic reactions
Important Disclaimer
The Moxifloxacin 400 Mg/250 Ml Fresenius Solution For Infusion 400 mg/250 ml Solution for infusion professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
